Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Giulia Aquilano is active.

Publication


Featured researches published by Giulia Aquilano.


Italian Journal of Pediatrics | 2013

Respiratory syncytial virus infection in infants and correlation with meteorological factors and air pollutants

Silvia Vandini; Luigi Corvaglia; Rosina Alessandroni; Giulia Aquilano; Concetta Marsico; Marica Spinelli; Marcello Lanari; Giacomo Faldella

BackgroundRespiratory Syncytial Virus (RSV) is the most important cause of severe respiratory infections in infants with seasonal epidemics. Environmental factors (temperature, humidity, air pollution) could influence RSV epidemics through their effects on virus activity and diffusion.MethodsWe conducted a retrospective study on a paediatric population who referred to our Paediatric Emergency Unit in order to analyze the correlation between weekly incidence of RSV positive cases during winter season in Bologna and meteorological factors and air pollutants concentration.ResultsWe observed a significant correlation between the incidence of RSV infections and the mean minimum temperature registered during the same week and the previous weeks.The weekly number of RSV positive cases was also correlated to the mean PM10 concentration of the week before.ConclusionsRSV epidemic trend in Bologna (Italy) is related to the mean minimum temperature, and the mean PM10 concentration.


Pediatric Research | 2011

Urinary neutrophil gelatinase-associated lipocalin at birth predicts early renal function in very low birth weight infants.

Gaetano La Manna; Silvia Galletti; Irene Capelli; Silvia Vandini; Katia Nisi; Giulia Aquilano; Rita Mancini; Elisa Carretta; Giovanni Montini; Giacomo Faldella; Sergio Stefoni

Preterm infants are exposed to conditions that can impair renal function. We evaluated the ability of serum and urinary neutrophil gelatinase-associated lipocalin (sNGAL and uNGAL) to predict renal function in the first weeks of life. From September 2008 to July 2009, infants weighing ≤1500 g at birth with no major congenital anomalies or sepsis were eligible. We measured sNGAL and uNGAL levels at birth. To evaluate renal function, we determined changes in serum creatinine (sCreat) and estimated GFR (eGFR) from birth to d 21. Forty neonates (mean GA, 27 ± 2 wk) completed the study. Renal function improved in 32 of 40 (80%) infants (normal renal function, NRF group) (sCreat, from 0.97 ± 0.2 to 0.53 ± 0.13 mg/dL; eGFR, from 15.3 ± 4.1 to 28.6 ± 7.9 mL/min), whereas renal function worsened in 8 of 40 (20%) infants (impaired renal function, IRF group) (sCreat, from 0.71 ± 0.27 to 0.98 ± 0.43 mg/dL; eGFR from 23 ± 14.7 to 16.4 ± 9.1 mL/min). The uNGAL/urinary creatinine (uCreat) ratio at birth was higher in the IRF group (31.05 ng/mg) than the NRF group (6.0 ng/mg), and uNGAL was significantly higher in IRF group, detecting IRF with a cutoff of 100 ng/mL. uNGAL levels at birth may have a predictive role in very LBW (VLBW) infants.


JIMD Reports | 2011

Generalized Arterial Calcification of Infancy: Fatal Clinical Course Associated with a Novel Mutation in ENPP1

Silvia Galletti; Yvonne Nitschke; Anna Maria Malavolti; Giulia Aquilano; Giacomo Faldella; Luigi Corvaglia; Frank Rutsch

Generalized arterial calcification of infancy (GACI) is a rare condition characterized by arterial calcification within the internal elastic lamina associated with intimal proliferation, leading to stenosis of great and medium-sized vessels. This disease, caused by mutations in multiple exons of ENPP1, frequently results in death in infancy. Nowadays, the most promising therapeutic compounds for this rare disease are bisphosphonates. We describe a case of GACI associated with the novel mutation c.653A>T (p.D218V) in ENPP1 on both alleles. The male infant was delivered prematurely and developed heart failure, severe hypertension, and diffuse calcifications of all arterial districts. He was treated with etidronate (18 mg/kg/day); however, the clinical condition did not improve, and a resolution of calcifications was not observed. The infant died within the 6th month of life of ischemic heart failure. We conclude that even if the diagnosis of GACI is established early and bisphosphonate treatment is started early, the prognosis can be very poor.


Journal of Chemotherapy | 2010

Hospitalization for Lower Respiratory Tract Disease in Preterm Infants: Effects of Prophylaxis with Palivizumab

Giacomo Faldella; Rosina Alessandroni; Giulia Aquilano; Silvia Vandini; Marcello Lanari; Michela Silvestri; A. Pistorio; Giovanni A. Rossi

Abstract To evaluate the effect of palivizumab prophylaxis on hospitalization for acute respiratory tract infections (RTI) in preterm infants, a prospective study was performed on a cohort of preterm infants [gestational age (GA) ≤32weeks], admitted at birth to a Neonatology Intensive Care Unit (NICU) (follow-up: 30-month after discharge). 154 palivizumab-recipients and 71 palivizumab-non-recipients were evaluated. During follow-up, a similar rate of hospitalization for RTI was found in the two groups (11.3% in palivizumab-non-recipients and 15.58% in palivizumab-recipients, P=0.39). However, when only infants hospitalized during their first respiratory syncytial virus (RSV) epidemic season and with a chronological age <6 months at admission were considered, the incidence rates for hospitalization was six-fold lower in the palivizumab-recipients (P=0.007). This study contributes to the definition of epidemiological data on RTI among preterm infants in Italy. These data support the usefulness of palivizumab prophylaxis for prevention of hospitalization for RTI in young preterm infants during the expected RSV epidemic season.


Clinical & Developmental Immunology | 2016

Altered Intracellular ATP Production by Activated CD4+ T-Cells in Very Preterm Infants

Giulia Aquilano; Maria Grazia Capretti; Francesca Nanni; Luigi Corvaglia; Arianna Aceti; Liliana Gabrielli; Angela Chiereghin; Giacomo Faldella; Tiziana Lazzarotto

Background. The neonatal immune system is not fully developed at birth; newborns have adequate lymphocytes counts but these cells lack function. Objective. To assess the activity of T-cells and the influence of the main perinatal factors in very preterm infants (birth weight < 1500 g). Design. Blood samples from 59 preterm infants (21/59 were dizygotic twins) were collected at birth and at 30 days of life to measure CD4+ T-cell activity using the ImmuKnow™ assay. Fifteen healthy adults were included as a control group. Results. CD4+ T-cell activity was lower in VLBW infants compared with adults (p < 0.001). Twins showed lower immune activity compared to singletons (p = 0.005). Infants born vaginally showed higher CD4+ T-cell activity compared to those born by C-section (p = 0.031); infants born after prolonged Premature Rupture of Membranes (pPROM) showed higher CD4+ T-cell activity at birth (p = 0.002) compared to infants born without pPROM. Low CD4+ T-cell activity at birth is associated with necrotizing enterocolitis (NEC) in the first week of life (p = 0.049). Conclusions. Preterm infants show a lack in CD4+ T-cell activity at birth. Perinatal factors such as intrauterine inflammation, mode of delivery, and zygosity can influence the adaptive immune activation capacity at birth and can contribute to exposing these infants to serious complications such as NEC.


Archives of Disease in Childhood | 2012

604 Urinary Ngal (Ungal) at Birth is Related to Bronchopulmonary Dysplasia in Preterm Infants

Silvia Vandini; Giulia Aquilano; Irene Capelli; Lt Corvaglia; Silvia Galletti; G. La Manna

Background and Aims Bronchopulmonary dysplasia (BPD) is a chronic lung disease associated with premature birth and early lung injury. The pathogenesis is multifactorial, including fluid and electrolytes balance that is dependent to renal development during the first weeks of life. We previously found a correlation between renal development during the first weeks of life and urinary neutrophil gelatinase-associated lipocalin (UNGAL) at birth in very low birth weight infants (VLBW). The aim of this study was to examine the relationship between urinary (UNGAL) and serum NGAL (SNGAL) at birth and BPD. Methods UNGAL and SNGAL were determined at birth in VLBW. BPD was defined as oxygen need at 36 week gestational age (GA). Statistical analysis was performed with chi square. Results 44 VLBW admitted at birth in our NICU were included in the study; 2 of them died during stay in NICU. 20/42 infants developed BPD: all were born at ≤ 29 week (GA) and 14 of them needed diuretics. High values of UNGAL (> 100 ng/ml) were observed more frequently among BPD treated with diuretics infants than in the other subjects (57% vs 28%, p=0.04). High levels of SNGAL (>150 ng/ml) were not significantly more frequent in VLBW with BPD. Conclusions These preliminary data show that high UNGAL at birth is a marker of impaired renal development and fluid balance in preterm newborns, that determine increased lung water and consequently contribute to BPD development.


Italian Journal of Pediatrics | 2014

Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome

F. Vitali; Silvia Galletti; Arianna Aceti; Giulia Aquilano; Marianna Fabi; Anna Balducci; Giacomo Faldella


Italian Journal of Pediatrics | 2014

Bi-level CPAP does not change central blood flow in preterm infants with respiratory distress syndrome.

Giulia Aquilano; Silvia Galletti; Arianna Aceti; F. Vitali; Giacomo Faldella


Early Human Development | 2011

Can UNGAL detected at birth be a good predictor of a hemodynamically significant PDA

Silvia Galletti; Anna Maria Malavolti; Giulia Aquilano; Silvia Vandini; Marica Spinelli; Giacomo Faldella


PEDIATRIA PREVENTIVA & SOCIALE | 2008

Problematiche alimentari in bambini prematuri: intervento integrato medico-psicologico

A. Piccioni; I. Malaguti; Federica Fantini; M. Scalcione; L. Ridolfi; Giulia Aquilano; Rosina Alessandroni; Giacomo Faldella; Elena Trombini

Collaboration


Dive into the Giulia Aquilano's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

F. Vitali

University of Bologna

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge